NanJing Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio
NanJing Pharmaceutical Co Ltd cash flow-to-debt ratio. NanJing Pharmaceutical Co Ltd (600713) has a Cash Flow-to-Debt Ratio of -0.04x as of September 2025, meaning its operating cash flow of CN¥-942.93 Million could theoretically repay 0% of its total liabilities (CN¥26.09 Billion) in one year. Check 600713 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of NanJing Pharmaceutical Co Ltd (1998–2024)
Cash flow-to-debt ratio of NanJing Pharmaceutical Co Ltd from 1998 to 2024. Historical debt coverage capacity for NanJing Pharmaceutical Co Ltd across 27 annual periods. Check 600713 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
NanJing Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio by Year (1998–2024)
NanJing Pharmaceutical Co Ltd cash flow-to-debt ratio by year from 1998 to 2024. Year-by-year debt coverage analysis for NanJing Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see NanJing Pharmaceutical Co Ltd cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.09x | CN¥2.14 Billion | CN¥22.89 Billion | ▲ +3.6% |
| 2023 | 0.09x | CN¥1.91 Billion | CN¥21.16 Billion | ▲ +429.6% |
| 2022 | -0.03x | CN¥-682.31 Million | CN¥24.96 Billion | ▼ -181.2% |
| 2021 | 0.03x | CN¥695.33 Million | CN¥20.65 Billion | ▲ +154.3% |
| 2020 | -0.06x | CN¥-1.15 Billion | CN¥18.59 Billion | ▼ -207.7% |
| 2019 | 0.06x | CN¥1.00 Billion | CN¥17.45 Billion | ▲ +342.3% |
| 2018 | -0.02x | CN¥-366.90 Million | CN¥15.45 Billion | ▼ -194.6% |
| 2017 | 0.03x | CN¥319.99 Million | CN¥12.74 Billion | ▲ +213.6% |
| 2016 | -0.02x | CN¥-240.88 Million | CN¥10.89 Billion | ▲ +28.4% |
| 2015 | -0.03x | CN¥-306.08 Million | CN¥9.91 Billion | ▲ +19.1% |
| 2014 | -0.04x | CN¥-341.01 Million | CN¥8.92 Billion | ▲ +9.8% |
| 2013 | -0.04x | CN¥-354.27 Million | CN¥8.36 Billion | ▼ -299.4% |
| 2012 | 0.02x | CN¥168.17 Million | CN¥7.91 Billion | ▲ +123.5% |
| 2011 | -0.09x | CN¥-692.53 Million | CN¥7.67 Billion | ▼ -639.4% |
| 2010 | 0.02x | CN¥119.08 Million | CN¥7.11 Billion | ▲ +378.2% |
| 2009 | 0.00x | CN¥20.22 Million | CN¥5.77 Billion | ▲ +258.8% |
| 2008 | 0.00x | CN¥4.33 Million | CN¥4.43 Billion | ▼ -94.8% |
| 2007 | 0.02x | CN¥81.08 Million | CN¥4.30 Billion | ▼ -64.4% |
| 2006 | 0.05x | CN¥161.31 Million | CN¥3.04 Billion | ▼ -14.1% |
| 2005 | 0.06x | CN¥165.57 Million | CN¥2.68 Billion | ▲ +856.7% |
| 2004 | 0.01x | CN¥16.26 Million | CN¥2.52 Billion | ▼ -32.4% |
| 2003 | 0.01x | CN¥19.27 Million | CN¥2.02 Billion | ▼ -81.8% |
| 2002 | 0.05x | CN¥68.75 Million | CN¥1.31 Billion | ▲ +970.8% |
| 2001 | -0.01x | CN¥-4.20 Million | CN¥697.93 Million | ▼ -105.1% |
| 2000 | 0.12x | CN¥87.68 Million | CN¥742.31 Million | ▲ +17.1% |
| 1999 | 0.10x | CN¥50.58 Million | CN¥501.56 Million | ▼ -42.7% |
| 1998 | 0.18x | CN¥77.45 Million | CN¥440.31 Million | — |